Planning Capital Management Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$99.2K Sell
112
-263
-70% -$236K 0.07% 134
2024
Q2
$340K Hold
375
0.24% 65
2024
Q1
$292K Sell
375
-55
-13% -$39.1K 0.21% 63
2023
Q4
$251K Buy
+430
New +$251K 0.2% 73

Other funds holding LLY

Planning Capital Management Corporation's LLY Position: Q3 2024 in Review

Planning Capital Management Corporation reduced its Eli Lilly (LLY) stake by 70% in Q3 2024, selling an estimated $236K and leaving 112 shares worth $99.2K. The position accounts for 0.07% of the portfolio, ranked #134.

Planning Capital Management Corporation first reported a position in LLY in Q4 2023 and has held it in 4 quarters since. The position peaked at $340K in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Planning Capital Management Corporation held 112 shares of Eli Lilly worth $99.2K as of Q3 2024.
  • Planning Capital Management Corporation sold 263 Eli Lilly shares in Q3 2024, an estimated $236K.
  • Eli Lilly made up 0.07% of Planning Capital Management Corporation's portfolio in Q3 2024, its #134 holding.
  • Planning Capital Management Corporation first reported a position in Eli Lilly in Q4 2023 and has held it in 4 quarters since.
  • Planning Capital Management Corporation's Eli Lilly position peaked at $340K in Q2 2024.
  • 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.